We are glad to announce that BSP Pharmaceuticals received two important awards during the 7th Annual World ADC Awards Ceremony.
The first award in the category “Best Contract Manufacturing (CMO) Provider” is the sixth in a row and consolidates BSP’s role in supporting the Global ADC Community by providing high quality integrated DS and DP manufacturing services.
The second award was assigned to BSP’s President and CEO, Aldo Braca, as “Individual input to the field”, in recognition of his strong commitment and his foresight in this new class of products and for the major role he played in sustaining the recent growth in the number of the approved ADC products.
“We are very happy and honored to have received these awards”, commented Aldo Braca, BSP Pharmaceuticals President & CEO. “BSP’s team is very active in trying to anticipate customer needs in development, clinical and commercial supplies.
We decided to play an important role as CDMO in the ADC ten years ago, and we have always been very consistent with this mission, trying to make available to the most qualified scientific community the means to be able to materialize its ideas as quickly as possible.
We are continuing to invest to open up new capacities, both for Drug Substances and Drug Products. We are convinced that this category of treatments is opening new horizons in the fight against cancer and, for many patients, will represent the strongest life expectancy.
BSP is working on most of the new products currently in pre-clinical and clinical and also those that are in the market. We are doing it without too much noise but with a lot of passion. If such an important Community, brought together by Hanson Wade, notices us and appreciates our work, then this shows us that we are going on the right path, it repays us for the work and pushes us to do more and more ”.
As part of the World ADC Digital Summit 2020, the 7th Annual World ADC Awards Ceremony took place digitally for the first time, due to the CoViD-19 pandemic.
The Annual World ADC Awards exist to commend excellence within antibody-drug conjugate research. It is a privilege to acknowledge those who push the boundaries, dedicating their careers and companies to the pursuit of fighting cancer.
These awards recognize that innovation, leadership, and devotion on a global platform. Across nine categories the awards will showcase the extraordinary endeavors, teamwork and commercial acumen that has propelled the field to the forefront of cancer research today.
The finalists and winner were shortlisted from over 1000 votes cast scientific proposal from each submission were evaluated by the Judging panel.
For the full list of winners, visit https://worldadc-awards.com/.